INSERM Unit 1163

INSERM Unit 1163 is a French biomedical research unit based in Paris affiliated with INSERM and associated with Université Paris Cité and Hôpital Necker–Enfants Malades. The unit conducts translational research bridging clinical trials at Assistance Publique–Hôpitaux de Paris with basic science carried out in university laboratories such as those at Collège de France, École normale supérieure (Paris), and Sorbonne Université. Its investigators collaborate with international centers including National Institutes of Health, Wellcome Trust, Max Planck Society, and European Molecular Biology Laboratory.

History

The unit was created amid restructuring of French research institutions following initiatives led by Ministère de l'Enseignement supérieur, de la Recherche et de l'Innovation and strategic plans influenced by reports from Agence nationale de la recherche. Its early years involved partnerships with clinical departments at Hôpital Cochin, Hôpital Necker–Enfants Malades, and research groups from Inserm Unit UMR S_1138 and Institut national de la santé et de la recherche médicale. Key milestones included participation in multicenter projects funded by the European Research Council and cooperative efforts with consortia coordinated by Institut Pasteur and CNRS. The unit's development paralleled national initiatives such as the Investissements d'avenir program and responses to outbreaks overseen by the Ministère des Solidarités et de la Santé.

Research Focus and Programs

Research programs emphasize translational studies at the intersection of genetics, immunology, infectious diseases, neurodevelopmental disorders, and rare diseases. Projects span from molecular investigations informed by technologies from CRISPR-Cas9 innovation to patient-oriented work leveraging protocols from ClinicalTrials.gov-registered studies and networks like European Reference Networks. Research themes include pathogen-host interactions studied alongside groups at Institut Pasteur, precision medicine initiatives aligned with France 2030, and genomic analyses using platforms established in collaboration with Genoscope and Human Genome Organisation. The unit contributes to training programs linked to Inserm Transfert and doctoral schools affiliated with Université Paris Cité and doctoral programs recognized by CNRS.

Organization and Leadership

The unit is structured into thematic teams led by principal investigators recruited from institutions such as Université Paris Cité, Sorbonne Université, and clinical departments at Assistance Publique–Hôpitaux de Paris. Leadership includes directors who have held positions in national bodies like INSERM’s executive committees and advisory roles for the European Commission's research directorates. Governance follows rules comparable to those used by Institut Pasteur and university hospital departments overseen by boards similar to those at AP-HP. Administrative and scientific advisory boards include external members from organizations such as National Institutes of Health, Wellcome Trust, and the European Molecular Biology Organization.

Facilities and Collaborations

Laboratory facilities are located within biomedical campuses shared with Hôpital Necker–Enfants Malades, featuring core platforms for genomics comparable to those at Genoscope, imaging suites akin to units at École normale supérieure (Paris), and bioinformatics resources paralleling services at European Bioinformatics Institute. The unit maintains clinical research facilities integrated with Assistance Publique–Hôpitaux de Paris and collaborates with international partners including National Institutes of Health, Max Planck Society, Wellcome Sanger Institute, and European Molecular Biology Laboratory. Collaborative networks extend to patient-advocacy groups such as associations modeled after AFM-Téléthon and multicenter clinical consortia funded through mechanisms used by the European Union and the European Research Council.

Publications and Impact

Investigators publish in journals comparable to Nature, Science, Cell, The Lancet, and New England Journal of Medicine, and contribute to specialist outlets such as Journal of Clinical Investigation, PLOS Biology, and Nature Communications. The unit’s work has been cited in policy reports by organizations like World Health Organization and has informed recommendations by bodies similar to Haute Autorité de Santé. Its translational outputs include contributions to clinical protocols used in hospitals like Hôpital Necker–Enfants Malades and collaborative patents filed in partnership with technology transfer offices modeled on Inserm Transfert and university incubators comparable to those at Université Paris Cité. The unit’s alumni have taken leadership roles at institutions such as Institut Pasteur, CNRS, and international universities including Harvard University and University of Oxford.

Category:Biomedical research institutes Category:Research institutes in France